Eric Jia-Sobota, Founder, Author at EverGlade Consulting - Page 2 of 10

Eric Jia-Sobota, Founder

Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Practice and the Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others. View Eric's resume at https://ericjia-sobota.com/

Eric Jia-Sobota
Superconductor microchip with blue overlay

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Broad Agency Announcement Defense Sciences Office (DSO) Office-wide BAA Defense Sciences Office HR001125S0013 Pioneering the Next Generation of Defense Research On June 3, 2025, the Defense Advanced Research Projects Agency (DARPA), through its Defense Sciences Office (DSO), announced an open solicitation under Broad Agency Announcement (BAA) HR001125S0013. This office-wide BAA serves as a mechanism for […]

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA Read More »

Rapid Response Test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness

Leave a Comment / All Posts, BARDA, Life Sciences / By

In a continued effort to bolster national preparedness against emerging biological threats, the Biomedical Advanced Research and Development Authority (BARDA) has released the Phase 2 issue of the “Biothreat Diagnostic Rapid Response” Solicitation (RPP-25-06-DxR2) on May 29, 2025, under its Rapid Response Partnership Vehicle (RRPV). BARDA is seeking to address pressing gaps in diagnostic test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness Read More »

radiation voltaics

Rads to Watts Proposers Day

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Program Overview Rads to Watts is a DARPA program dedicated to pioneering innovative methods for directly converting nuclear radiation into electricity, with a primary emphasis on radiation voltaics (also known as radiovoltaics). The program’s long-term goal is to develop radiovoltaic systems capable of transforming high-power nuclear radiation into kilowatts of electrical energy. Achieving operation at

Rads to Watts Proposers Day Read More »

Two scientists in lab coats at a computer discussing their findings

DARPA’s RFI on Advanced Disease Outbreak Simulation

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Advanced Disease Outbreaks Simulation Capabilities The Defense Advanced Research Projects Agency (DARPA) has issued a new Request for Information (RFI) titled “Advanced Disease Outbreaks Simulation Capabilities” (DARPA-SN-25-72). This announcement seeks insights from the research and development community on cutting-edge outbreak modeling tools to increase understanding of outbreak dynamics and improve future public health emergency preparedness.

DARPA’s RFI on Advanced Disease Outbreak Simulation Read More »

Pentagon Department of Defense

DPA Title III RFI on Advanced Canopy Transparencies

Leave a Comment / DPA, Emerging Technologies / By

Defense Production Act (DPA) Title III Request for Information (RFI) on Advanced Canopy Transparencies In an effort to fortify the defense industrial base and enhance the reliability of critical aviation components, the U.S. Air Force Research Laboratory (AFRL) has issued a Request for Information (RFI) under Title III of the Defense Production Act (DPA). This

DPA Title III RFI on Advanced Canopy Transparencies Read More »

Conveyor belt with blue capsules medicine

ASPR RFI: Public Health Industrial Base Capabilities and Capacities: Essential Medicines

Leave a Comment / ASPR-IBx, Life Sciences / By

ASPR Industrial Base Management and Supply Chain Request for Information (RFI) Understanding the RFI The Public Health Industrial Base Capabilities and Capacities: Essential Medicines RFI is seeking detailed input from domestic manufacturers and industry stakeholders to better understand the current capabilities and constraints in producing a list of 28 designated essential medicines. The scope includes

ASPR RFI: Public Health Industrial Base Capabilities and Capacities: Essential Medicines Read More »

Close-up of Medical Ampoule Production Line at Modern Modern Pharmaceutical Factory. Glass Ampoules are being Filled. Medication Manufacturing Process.

DTRA’s RAVEN RFI Seeks Multivalent Vaccine Innovation

Leave a Comment / All Posts, DTRA, Life Sciences / By

Reimagining the Future of Vaccines: DTRA’s RAVEN RFI The Defense Threat Reduction Agency (DTRA), through its Joint Science and Technology Office (JSTO), has announced a new Request for Information (RFI) under the initiative titled Reimagining Available Vaccines and Envisioning Novelty (RAVEN). This RFI reflects DTRA’s responsibility to prepare the U.S. warfighter for current and emerging

DTRA’s RAVEN RFI Seeks Multivalent Vaccine Innovation Read More »

The White House Initiatives

White House Unveils New Initiatives for Critical Medicines and Biological Research Safety

Leave a Comment / All Posts, ARPA-H, BARDA, Life Sciences / By

Promoting Domestic Production of Critical Medicines The White House is pushing to see more state-of-the-art pharmaceutical manufacturing facilities within the United States to strengthen the supply of essential medicines. On May 5, 2025, the President signed an Executive Order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines.” The goal of this order is

White House Unveils New Initiatives for Critical Medicines and Biological Research Safety Read More »

3D rendering of Lymphocytes

DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats

Leave a Comment / All Posts, JPEO, Life Sciences / By

A New Direction: Host-Directed, Not Pathogen-Specific Unlike traditional antivirals or antibiotics, host-directed therapeutics (HDTs) focus on modulating the patient’s immune response rather than targeting a specific pathogen. This “threat-agnostic” approach is especially promising in an era marked by evolving biological agents and unpredictable infectious threats. The DoD is particularly interested in repurposed FDA-approved therapeutics or

DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats Read More »

Chemical Threat Readiness

Advancing Chemical Threat Readiness: The MCDC’s New Call for Prototypes

Leave a Comment / DTRA, Life Sciences / By

Advancing Chemical Threat Readiness: The MCDC’s New Call for Prototypes April 2025 marks another pivotal moment for U.S. defense readiness in chemical and biological threat detection. Through the Medical CBRN Defense Consortium (MCDC), the Army Contracting Command has issued Solicitation RPP-25-04 seeking Enhanced White Papers for a groundbreaking prototype: the Assay Expansion for Chemical Diagnostic

Advancing Chemical Threat Readiness: The MCDC’s New Call for Prototypes Read More »

immunoassay IEID Lab Solicitation

BARDA’s Central IEID Lab Solicitation: Strengthening Immunoassay Readiness for Pandemic Threats

Leave a Comment / All Posts, BARDA, Life Sciences / By

Why It Matters The rise of highly pathogenic avian influenza (HPAI) strains like H5N1, their spread to livestock, and increasing zoonotic infections in the U.S. has underscored the need for rapid, accurate immune assay infrastructure. BARDA’s RRPV initiative calls for laboratories with existing capabilities to function as a central immunoassay laboratory and perform quality-assured immunoassays

BARDA’s Central IEID Lab Solicitation: Strengthening Immunoassay Readiness for Pandemic Threats Read More »

The White House 2025 Executive Order

April 2025 Executive Order

Leave a Comment / AI, DIU, Emerging Technologies / By

Key Takeaways from the April 2025 Executive Order On April 2, 2025, President Trump issued an Executive Order titled “Modernizing Defense Acquisitions and Spurring Innovation in the Defense Industrial Base.” This directive signals a major shift in how the Department of Defense (DoD) acquires technology, emphasizing speed, flexibility, and inclusion of non-traditional contractors. 1. Streamlining

April 2025 Executive Order Read More »

Scroll to Top